Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Depression in Alzheimer's Disease
NCT01841125Phase 4Completed
- Sponsor
- Konkuk University Medical Center
- Start
- Nov 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Konkuk University Medical Center. Started Nov 2011; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01841125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841125.